Date: 2015-11-10
Type of information: Services contract
Compound:
Company: Novasep (France) Centre for Process Innovation (CPI) (UK)
Therapeutic area: Technology - Services
Type agreement: services contract
Action mechanism:
Disease:
Details: * On November 10, 2015, Novasep and the Centre for Process Innovation (CPI), a UK-based technology innovation centre, announced they have equipped the UK National Biologics Manufacturing Centre with BioSC Lab, the latest state-of-the art technology for protein purification. CPI’s mandate is to get UK companies up and running in technological areas that offer the largest potential impact on the future of UK and global manufacturing. It provides services to SMEs that decrease time to market for novel products or processes. Within this framework, the CPI has been keen to introduce breakthrough continuous processes in the UK biopharmaceutical sector, such as Novasep’s BioSC Lab. These enable developers to reduce equipment footprint and increase process yields, thereby saving time and money. BioSC Lab is flexible and supports any process operating mode, including batch parallel batch and continuous. It is specifically designed to quickly provide the operator with the best operational parameters for purifying and converting a batch biochromatography recipe into a continuous, optimized one. Its simulation software BioSC Predict frees the process developer to set the most efficient mode and parameters to purify biomolecules such as monoclonal antibodies (mAbs), blood factors and other proteins.
Financial terms:
Latest news:
